Straumann Holding AG
SAUHF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$20.5B
Close$
Earnings Call Q4 2025
February 18, 2026 - AI Summary
Strong Financial Performance: The Straumann Group reported revenue of CHF 2.6 billion in 2025, reflecting an organic growth of 8.9% and a reported growth of 4.1% after accounting for currency translation. The core EBIT margin increased to 26.5% (25.2% including currency effects), showcasing resilience despite external challenges like tariffs and foreign exchange pressures.
Market Share Gains and Product Innovation: The company successfully increased its market share from 12.5% to 14% over the year, primarily driven by the launch of innovative products, notably the iEXCEL implant, which achieved over 1 million sales, marking it as the most successful launch in the company's history. Continued focus on innovation, education, and digitalization positions the company well for future growth.
Positive Outlook for 2026: The company anticipates high single-digit organic revenue growth in 2026, bolstered by expected favorable conditions in key markets including China, where a recovery is anticipated post the Value-Based Pricing (VBP) process. The orthodontics business is also set to benefit from the transition to Smartee manufacturing, expected to enhance quality and efficiency.
Exclusive for Stockcircle Pro members
Sign up
$28.76
77.6% downside
Current Fair Value
77.6% downsideOvervalued by 77.6% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $20.50 Billion |
|---|---|
| Enterprise Value | $20.63 Billion |
| Annual dividend | $1.62 |
| Dividend yield | 0.93% |
| Earnings per Share | $2.24 |
| Beta | 1.5 |
| Outstanding Shares | 159,682,000 |
Return
| Return on Equity | 33.66% |
|---|---|
| Return on Assets | 19.70% |
| Return on Invested Capital | 51.42% |
Valuation & Multiples
| P/E Ratio | 46.01 |
|---|---|
| PEG | 846.68 |
| Price to Sales | 4.01 |
| Price to Book Ratio | 9.17 |
| Enterprise Value to Revenue | 3.96 |
| Enterprise Value to EBIT | 12.86 |
| Enterprise Value to Net Income | 27 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.22 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 28, 2026
EPS Estimate
$1.97
Consensus analyst estimateRevenue Estimate
$1.70 B
Consensus analyst estimateNext Earnings Call
Expected Date
February 24, 2027
EPS Estimate
$2.03
Consensus analyst estimateRevenue Estimate
$1.67 B
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Straumann Holding AG
11,342 employees
CEO: Guillaume Daniellot
Straumann Holding AG engages in the provision of implant, restorative, and regenerative dentistry solutions to dental professionals and laboratories. It operates through the following segments: Sales Europe, Sales Distributor & Emerging ...